SCHEMBL5809953

SCHEMBL5809953

O=C(N/N=C/Cc1ccc(F)cc1O)c1ccncc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.50
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
RAB9A P51151 4/20 0.50
L3MBTL1 Q9Y468 7/20 0.49
HTT P42858 2/20 0.49
KDM4E B2RXH2 5/20 0.48
MAPT P10636 3/20 0.48
TDP1 Q9NUW8 3/20 0.48
MITF O75030 2/20 0.48
ASF1A Q9Y294 1/20 0.48
GPR174 Q9BXC1 1/20 0.48
CYP2D6 P10635 1/20 0.47
GAA P10253 2/20 0.46
POLB P06746 1/20 0.46
MPO P05164 2/20 0.46
NT5E P21589 1/20 0.46
ALDH1A1 P00352 1/20 0.45
USP2 O75604 1/20 0.44
MCOLN3 Q8TDD5 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5809674 1.00 NPC1 (0.50) NPC1MEN1KMT2ARAB9AL3MBTL1
SCHEMBL5809769 0.84 NPC1 (0.61) NPC1MEN1KMT2ARAB9AL3MBTL1
SCHEMBL5809458 0.83 L3MBTL1 (0.50) NPC1MEN1KMT2ARAB9AL3MBTL1
SCHEMBL5809442 0.83 L3MBTL1 (0.50) NPC1MEN1KMT2ARAB9AL3MBTL1
SCHEMBL5810164 0.79 MEN1 (0.78) NPC1MEN1KMT2ARAB9AL3MBTL1
SCHEMBL5809160 0.79 MEN1 (0.78) NPC1MEN1KMT2ARAB9AL3MBTL1
SCHEMBL5809159 0.79 MEN1 (0.78) NPC1MEN1KMT2ARAB9AL3MBTL1
SCHEMBL5814788 0.77 POLB (0.56) NPC1MEN1KMT2ARAB9AHTT
SCHEMBL5812806 0.77 POLB (0.56) NPC1MEN1KMT2ARAB9AHTT
SCHEMBL5809224 0.77 NPC1 (0.59) NPC1MEN1KMT2ARAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO claimed
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO disclosed